Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHA:688179)
China · Delayed Price · Currency is CNY 18.95
-0.63 (-3.22%)
At close: Sep 10, 2026
SHA:688179 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,835 | 4,138 | 3,828 | 3,796 | 5,108 | 7,935 | |
Market Cap Growth | 59.81% | 8.10% | 0.84% | -25.69% | -35.63% | -1.48% |
Enterprise Value | 6,784 | 4,245 | 3,789 | 3,607 | 4,824 | 7,487 |
Last Close Price | 18.95 | 12.41 | 11.27 | 10.98 | 14.67 | 22.64 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 45.65 | 40.55 | 38.76 | 44.23 | 55.06 | 88.80 |
Forward PE | 38.67 | 32.23 | 26.93 | 30.05 | - | - |
PS Ratio | 8.64 | 5.95 | 7.17 | 9.42 | 13.51 | 27.59 |
PB Ratio | 4.39 | 3.56 | 3.35 | 3.66 | 5.24 | 9.24 |
P/TBV Ratio | 7.43 | 7.75 | 4.21 | 3.80 | 5.45 | 9.48 |
P/FCF Ratio | 33.05 | 11.77 | 33.00 | 375.59 | - | - |
P/OCF Ratio | 28.92 | 10.33 | 25.26 | 68.05 | - | 529.02 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 8.57 | 6.10 | 7.10 | 8.95 | 12.76 | 26.03 |
EV/EBITDA Ratio | 27.83 | 21.80 | 24.83 | 32.95 | 44.95 | 73.59 |
EV/EBIT Ratio | 32.80 | 24.55 | 29.93 | 39.11 | 50.98 | 81.36 |
EV/FCF Ratio | 32.80 | 12.08 | 32.67 | 356.87 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.30 | 0.67 | 0.39 | 0.35 | 0.35 | 0.02 |
Debt / EBITDA Ratio | 1.89 | 3.73 | 2.69 | 2.96 | 2.99 | 0.12 |
Debt / FCF Ratio | 2.23 | 2.20 | 3.82 | 35.47 | - | - |
Net Debt / Equity Ratio | -0.17 | -0.10 | -0.06 | -0.21 | -0.29 | -0.45 |
Net Debt / EBITDA Ratio | -1.12 | -0.60 | -0.43 | -1.98 | -2.62 | -3.80 |
Net Debt / FCF Ratio | -1.25 | -0.33 | -0.57 | -21.49 | 2.67 | 3.93 |
Asset Turnover | 0.36 | 0.31 | 0.33 | 0.27 | 0.31 | 0.32 |
Inventory Turnover | 0.51 | 0.50 | 0.42 | 0.40 | 0.56 | 0.78 |
Quick Ratio | 1.25 | 1.35 | 2.64 | 5.90 | 4.32 | 6.95 |
Current Ratio | 2.03 | 2.04 | 5.15 | 10.22 | 7.23 | 10.37 |
Return on Equity (ROE) | 13.44% | 11.71% | 10.62% | 8.54% | 10.12% | 10.67% |
Return on Assets (ROA) | 5.80% | 4.88% | 4.82% | 3.86% | 4.91% | 6.41% |
Return on Invested Capital (ROIC) | 14.67% | 14.29% | 12.11% | 11.02% | 14.25% | 21.89% |
Return on Capital Employed (ROCE) | 11.00% | 9.30% | 8.10% | 6.60% | 7.20% | 10.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.07% | 2.47% | 2.58% | 2.26% | 1.82% | 1.13% |
FCF Yield | 3.03% | 8.50% | 3.03% | 0.27% | -2.06% | -1.24% |
Dividend Yield | 0.73% | 1.13% | 1.77% | 1.63% | 0.73% | 0.54% |
Payout Ratio | 65.02% | 97.84% | 63.73% | 41.22% | 43.52% | 56.47% |
Buyback Yield / Dilution | -3.33% | 3.33% | -12.41% | 12.51% | -4.75% | -25.43% |
Total Shareholder Return | -2.60% | 4.46% | -10.64% | 14.14% | -4.02% | -24.89% |